Mrv1718003231811362D 16 17 0 0 0 0 999 V2000 -2.0637 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3492 1.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0796 1.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7782 1.0312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.3492 1.8562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7942 0.6187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.5087 -1.4437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5087 -0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2933 -0.3638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.2933 -1.6987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.7782 -1.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7942 -1.8562 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0796 -1.4437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7942 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6347 0.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0796 -0.6187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 4 1 1 0 0 0 0 15 2 2 0 0 0 0 5 2 1 0 0 0 0 3 15 1 0 0 0 0 6 3 1 0 0 0 0 14 6 1 0 0 0 0 8 7 1 0 0 0 0 10 7 1 0 0 0 0 12 7 2 0 0 0 0 9 8 1 0 0 0 0 14 8 2 0 0 0 0 11 9 2 0 0 0 0 11 10 1 0 0 0 0 13 12 1 0 0 0 0 13 16 2 0 0 0 0 14 16 1 0 0 0 0 M END > DB11337 > drugbank > C\C(CO)=C/CNC1=C2N=CNC2=NC=N1 > InChI=1S/C10H13N5O/c1-7(4-16)2-3-11-9-8-10(13-5-12-8)15-6-14-9/h2,5-6,16H,3-4H2,1H3,(H2,11,12,13,14,15)/b7-2+ > UZKQTCBAMSWPJD-FARCUNLSSA-N > C10H13N5O > 219.2431 > 219.112010063 > 5 > 29 > 22.929776527461744 > 1 > 3 > 0 > 1 > (2E)-2-methyl-4-[(7H-purin-6-yl)amino]but-2-en-1-ol > 0.49 > -0.19129121633333293 > -2.89 > 0 > 2 > 0 > 15.162093082491896 > 10.212541711463365 > 3.455349774855455 > 86.72000000000001 > 64.60579999999999 > 4 > 1 > 2.83e-01 g/l > zeatin > 0 > DB11337 > experimental > Zeatin > (E)-2-methyl-4-(1H-purin-6-ylamino)-2-buten-1-ol; (E)-2-methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol; (E)-2-methyl-4-(purin-6-ylamino)-2-buten-1-ol; (E)-zeatin; N6-(4-Hydroxyisopentenyl)adenine; trans-Zeatin > ObagiGentle Rejuvenati Gentle Rejuvenation $$$$